Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 50

1.

Rethinking the metastatic cascade as a therapeutic target.

Mina LA, Sledge GW Jr.

Nat Rev Clin Oncol. 2011 Jun;8(6):325-32. doi: 10.1038/nrclinonc.2011.59. Review.

PMID:
21502993
2.

Cell surface glycan-lectin interactions in tumor metastasis.

Rambaruth ND, Dwek MV.

Acta Histochem. 2011 Oct;113(6):591-600. doi: 10.1016/j.acthis.2011.03.001. Review.

PMID:
21501858
3.

Overexpression of fatty acid synthase in Middle Eastern epithelial ovarian carcinoma activates AKT and Its inhibition potentiates cisplatin-induced apoptosis.

Uddin S, Jehan Z, Ahmed M, Alyan A, Al-Dayel F, Hussain A, Bavi P, Al-Kuraya KS.

Mol Med. 2011;17(7-8):635-45. doi: 10.2119/molmed.2011.00046.

4.

mTORC1 and mTORC2 regulate EMT, motility, and metastasis of colorectal cancer via RhoA and Rac1 signaling pathways.

Gulhati P, Bowen KA, Liu J, Stevens PD, Rychahou PG, Chen M, Lee EY, Weiss HL, O'Connor KL, Gao T, Evers BM.

Cancer Res. 2011 May 1;71(9):3246-56. doi: 10.1158/0008-5472.CAN-10-4058.

5.

CD44: can a cancer-initiating cell profit from an abundantly expressed molecule?

Zöller M.

Nat Rev Cancer. 2011 Apr;11(4):254-67. doi: 10.1038/nrc3023. Review.

PMID:
21390059
6.

Global cancer statistics.

Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D.

CA Cancer J Clin. 2011 Mar-Apr;61(2):69-90. doi: 10.3322/caac.20107. Erratum in: CA Cancer J Clin. 2011 Mar-Apr;61(2):134.

7.

MET signalling: principles and functions in development, organ regeneration and cancer.

Trusolino L, Bertotti A, Comoglio PM.

Nat Rev Mol Cell Biol. 2010 Dec;11(12):834-48. doi: 10.1038/nrm3012. Review.

PMID:
21102609
8.
9.

HO-3867, a synthetic compound, inhibits the migration and invasion of ovarian carcinoma cells through downregulation of fatty acid synthase and focal adhesion kinase.

Selvendiran K, Ahmed S, Dayton A, Ravi Y, Kuppusamy ML, Bratasz A, Rivera BK, Kálai T, Hideg K, Kuppusamy P.

Mol Cancer Res. 2010 Sep;8(9):1188-97. doi: 10.1158/1541-7786.MCR-10-0201.

10.

Sprouty-2 controls c-Met expression and metastatic potential of colon cancer cells: sprouty/c-Met upregulation in human colonic adenocarcinomas.

Holgren C, Dougherty U, Edwin F, Cerasi D, Taylor I, Fichera A, Joseph L, Bissonnette M, Khare S.

Oncogene. 2010 Sep 23;29(38):5241-53. doi: 10.1038/onc.2010.264.

11.

Fatty acid synthase inhibitor cerulenin suppresses liver metastasis of colon cancer in mice.

Murata S, Yanagisawa K, Fukunaga K, Oda T, Kobayashi A, Sasaki R, Ohkohchi N.

Cancer Sci. 2010 Aug;101(8):1861-5. doi: 10.1111/j.1349-7006.2010.01596.x.

12.

Inhibition of fatty acid synthase suppresses c-Met receptor kinase and induces apoptosis in diffuse large B-cell lymphoma.

Uddin S, Hussain AR, Ahmed M, Bu R, Ahmed SO, Ajarim D, Al-Dayel F, Bavi P, Al-Kuraya KS.

Mol Cancer Ther. 2010 May;9(5):1244-55. doi: 10.1158/1535-7163.MCT-09-1061.

13.

CD44, a therapeutic target for metastasising tumours.

Orian-Rousseau V.

Eur J Cancer. 2010 May;46(7):1271-7. doi: 10.1016/j.ejca.2010.02.024. Review.

PMID:
20303742
14.

Metabolic profiling in colorectal cancer reveals signature metabolic shifts during tumorigenesis.

Ong ES, Zou L, Li S, Cheah PY, Eu KW, Ong CN.

Mol Cell Proteomics. 2010 Feb 10. [Epub ahead of print]

15.

MET molecular mechanisms and therapies in lung cancer.

Lawrence RE, Salgia R.

Cell Adh Migr. 2010 Jan-Mar;4(1):146-52. Review.

16.

Metabolic genes in cancer: their roles in tumor progression and clinical implications.

Furuta E, Okuda H, Kobayashi A, Watabe K.

Biochim Biophys Acta. 2010 Apr;1805(2):141-52. doi: 10.1016/j.bbcan.2010.01.005. Review.

17.

Differential protein expression on the cell surface of colorectal cancer cells associated to tumor metastasis.

Luque-García JL, Martínez-Torrecuadrada JL, Epifano C, Cañamero M, Babel I, Casal JI.

Proteomics. 2010 Mar;10(5):940-52. doi: 10.1002/pmic.200900441.

PMID:
20049862
18.

Frequent expression of the high molecular, 673-bp CD44v3,v8-10 variant in colorectal adenomas and carcinomas.

Kopp R, Fichter M, Schalhorn G, Danescu J, Classen S.

Int J Mol Med. 2009 Nov;24(5):677-83.

PMID:
19787202
19.

High prevalence of fatty acid synthase expression in colorectal cancers in Middle Eastern patients and its potential role as a therapeutic target.

Uddin S, Hussain AR, Ahmed M, Abubaker J, Al-Sanea N, Abduljabbar A, Ashari LH, Alhomoud S, Al-Dayel F, Bavi P, Al-Kuraya KS.

Am J Gastroenterol. 2009 Jul;104(7):1790-801. doi: 10.1038/ajg.2009.230.

PMID:
19491830
20.

Increased expression of fatty acid synthase in human aberrant crypt foci: possible target for colorectal cancer prevention.

Kearney KE, Pretlow TG, Pretlow TP.

Int J Cancer. 2009 Jul 1;125(1):249-52. doi: 10.1002/ijc.24356.

Items per page

Supplemental Content

Support Center